These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 19509016)

  • 21. Distinct mechanisms for the induction and maintenance of allograft tolerance with CTLA4-Fc treatment.
    Tran HM; Nickerson PW; Restifo AC; Ivis-Woodward MA; Patel A; Allen RD; Strom TB; O'Connell PJ
    J Immunol; 1997 Sep; 159(5):2232-9. PubMed ID: 9278311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-β-Expressing Mesenchymal Stem Cells Induce Local Tolerance in a Rat Liver Transplantation Model of Acute Rejection.
    Tang J; Yang R; Lv L; Yao A; Pu L; Yin A; Li X; Yu Y; Nyberg SL; Wang X
    Stem Cells; 2016 Nov; 34(11):2681-2692. PubMed ID: 27333806
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Requirement of B7-H1 in mesenchymal stem cells for immune tolerance to cardiac allografts in combination therapy with rapamycin.
    Wang H; Qi F; Dai X; Tian W; Liu T; Han H; Zhang B; Li H; Zhang Z; Du C
    Transpl Immunol; 2014 Aug; 31(2):65-74. PubMed ID: 24978830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment.
    Lee SJ; Kim HJ; Byun NR; Park CG
    Cell Transplant; 2020; 29():963689720913876. PubMed ID: 32216448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 17 (IL-17)-Induced Mesenchymal Stem Cells Prolong the Survival of Allogeneic Skin Grafts.
    Ma T; Wang X; Jiao Y; Wang H; Qi Y; Gong H; Zhang L; Jiang D
    Ann Transplant; 2018 Aug; 23():615-621. PubMed ID: 30166501
    [TBL] [Abstract][Full Text] [Related]  

  • 26. iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants.
    Khan MA; Alanazi F; Ahmed HA; Shamma T; Kelly K; Hammad MA; Alawad AO; Assiri AM; Broering DC
    Stem Cell Res Ther; 2019 Sep; 10(1):290. PubMed ID: 31547869
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Kidney-derived mesenchymal stromal cells modulate dendritic cell function to suppress alloimmune responses and delay allograft rejection.
    Huang Y; Chen P; Zhang CB; Ko GJ; Ruiz M; Fiorina P; Hussain MA; Wasowska BA; Rabb H; Womer KL
    Transplantation; 2010 Dec; 90(12):1307-11. PubMed ID: 21048532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells.
    Zangi L; Margalit R; Reich-Zeliger S; Bachar-Lustig E; Beilhack A; Negrin R; Reisner Y
    Stem Cells; 2009 Nov; 27(11):2865-74. PubMed ID: 19750539
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lentivirus-mediated IL-10-expressing Bone Marrow Mesenchymal Stem Cells promote corneal allograft survival
    Lu X; Ru Y; Chu C; Lv Y; Gao Y; Jia Z; Huang Y; Zhang Y; Zhao S
    Theranostics; 2020; 10(18):8446-8467. PubMed ID: 32724480
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance.
    Gregori S; Casorati M; Amuchastegui S; Smiroldo S; Davalli AM; Adorini L
    J Immunol; 2001 Aug; 167(4):1945-53. PubMed ID: 11489974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marginal mass islet transplantation with autologous mesenchymal stem cells promotes long-term islet allograft survival and sustained normoglycemia.
    Solari MG; Srinivasan S; Boumaza I; Unadkat J; Harb G; Garcia-Ocana A; Feili-Hariri M
    J Autoimmun; 2009 Mar; 32(2):116-24. PubMed ID: 19217258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Marrow Mesenchymal Stem Cells Effectively Reduce Histologic Changes in a Rat Model of Chronic Renal Allograft Rejection.
    Yu P; Wang Z; Liu Y; Xiao Z; Guo Y; Li M; Zhao M
    Transplant Proc; 2017 Nov; 49(9):2194-2203. PubMed ID: 29149982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of transplantation tolerance to fully mismatched cardiac allografts by T cell mediated delivery of alloantigen.
    Tian C; Yuan X; Jindra PT; Bagley J; Sayegh MH; Iacomini J
    Clin Immunol; 2010 Aug; 136(2):174-87. PubMed ID: 20452826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stromal cells in renal transplantation: opportunities and challenges.
    Casiraghi F; Perico N; Cortinovis M; Remuzzi G
    Nat Rev Nephrol; 2016 Apr; 12(4):241-53. PubMed ID: 26853275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B10 cells play a role in the immune modulation of pro- and anti-inflammatory immune responses in mouse islet allograft rejection.
    Qin Y; Zhang M; Jiang RM; Wu Q; Xu XY; Chen H; Yang T
    Cell Immunol; 2016 Dec; 310():184-192. PubMed ID: 27667759
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction.
    Mias C; Lairez O; Trouche E; Roncalli J; Calise D; Seguelas MH; Ordener C; Piercecchi-Marti MD; Auge N; Salvayre AN; Bourin P; Parini A; Cussac D
    Stem Cells; 2009 Nov; 27(11):2734-43. PubMed ID: 19591227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of mouse pancreatic islet function by co‑culture with hypoxia pre‑treated mesenchymal stromal cells.
    Xiang C; Xie QP
    Mol Med Rep; 2018 Sep; 18(3):2589-2598. PubMed ID: 30015882
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conversion of Th17 into IL-17A(neg) regulatory T cells: a novel mechanism in prolonged allograft survival promoted by mesenchymal stem cell-supported minimized immunosuppressive therapy.
    Obermajer N; Popp FC; Soeder Y; Haarer J; Geissler EK; Schlitt HJ; Dahlke MH
    J Immunol; 2014 Nov; 193(10):4988-99. PubMed ID: 25305313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Netrin-1 prolongs skin graft survival by inducing the transformation of mesenchymal stem cells from pro-rejection to immune-tolerant phenotype.
    Liu LP; Chen W; Fan Y; Qi BY; Wang Z; Shi BY
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8741-8750. PubMed ID: 31696460
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal stem cells overexpressing IL-35: a novel immunosuppressive strategy and therapeutic target for inducing transplant tolerance.
    Guo H; Li B; Wang W; Zhao N; Gao H
    Stem Cell Res Ther; 2018 Sep; 9(1):254. PubMed ID: 30257721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.